National Cancer Institute (NCI) Small Business Innovation Research (SBIR) Innovative Concept Phase I Award Program

National Institutes of Health See every open bid from this agency →

In plain English

The National Cancer Institute wants small businesses to propose Phase I SBIR research to develop cancer technologies. Topics include treatments or prevention for pediatric and rare cancers, plus devices, diagnostics, and digital health tools for detecting or treating them. Preliminary data is not required, but proposals must explain the scientific basis, product path, and proof-of-concept work; non-exempt human-subjects research is not supported. Proposals are due by 5:00 p.m. on September 21, 2026, and Amendment #3 must be submitted with a signed SF30 page 1.

About this opportunity

THIS EDIT IS TO POST AMENDMENT #3. AMENDMENT #3 IS TO provide key questions and answers received in writing by email. Offerors are required to submit a signed copy of the SF30 Amendment (page 1 only) with their Business Proposal submission. The deadline for receipt of proposals remains unchanged at 5:00pm, September 21, 2026. All other terms and conditions of the solicitation remain unchanged. PLEASE SEE ATTACHED AMENDMENT #3 PDF. ____ THIS EDIT IS TO POST AMENDMENT #2. AMENDMENT #2 IS TO remove the Data Management Sharing Plan requirement and all references under Sections

5.9 Management and Sharing of Research Data,

6.1 Evaluation Process, Evaluation of Data Management and Sharing Plan,

Time remaining

Closes Sep 21, 2026

07Days

13Hours

12Min

15Sec